Digital transformation of the care pathway for COPD patients

Can artificial intelligence-based insights transform care pathways and assist patients with the management of their long-term conditions? Dr Carlin explores his team’s fully digital care model.
This is a secured video. To access it for the first time you must fill-in your email address above.

Key facts

  • ERS CONGRESS 2022
  • WITH DR CHRIS CARLIN
  • CLINICAL ADOPTION IN HIGH-FLOW THERAPY

Content

COPD patients are keen to avoid exacerbations and hospitalisation. In this presentation, Dr Carlin presents a fully digital care pathway that includes a patient app and artificial intelligence-based insights. He explains how it can help patients to manage their health effectively within the community by simplifying management, identifying risk, improving communication, and delivering timely health advice.

In this webinar, Dr Carlin describes the digital COPD service model that has been developed on the back of the RECEIVER trial1 and shares a video testimonial from a patient who has benefited from this experience. As well as explaining how the service has been co-designed, structured and delivered with patient input, he presents data around patient uptake of and interaction with the service and addresses the issue of digital exclusion. Additional data show how the service is improving health outcomes and maintaining quality of life for patient. The service is delivering substantial healthcare resource utilisation savings for the health board without demanding any significant increase in delivery resources.

Register to watch the webinar if you’d like to learn how the design and delivery of digital services can support effective COPD care in the community and why programmes like this could be the tip of the digital iceberg.

Speakers

Dr Chris Carlin

Queen Elizabeth University Hospital, UK

Looking for more information about high-flow treatment for COPD patients?

Research in home high-flow therapy for COPD

Discover key findings from recent clinical research on the mechanisms of action of home high-flow therapy and the clinical outcomes in patients with COPD.
Learn more

The HiFAE trial

Read more about the new French randomised controlled trial: HiFAE. The main objective of this study is to evaluate the efficacy of home high-flow therapy with oxygen vs standard oxygen therapy for the reduction of acute COPD exacerbations.
Learn more

Home high-flow therapy for COPD

Learn how home high flow therapy could be indicated for domiciliary use in COPD patients experiencing secretion management issues.
Learn more

1. RECEIVER trial: positive early experience and sustained patient engagement with a digital service model for COPD management Anna Taylor, Rebecca Scott, Grace Mcdowell, Paul Mcginness, David Lowe, Chris Carlin European Respiratory Journal Sep 2020, 56 (suppl 64) 1365; DOI: 10.1183/13993003.congress-2020.1365